...
首页> 外文期刊>Clinical and diagnostic laboratory immunology >Novel Approach for Specific Detection of Herpes Simplex Virus Type 1 and 2 Antibodies and Immunoglobulin G and M Antibodies
【24h】

Novel Approach for Specific Detection of Herpes Simplex Virus Type 1 and 2 Antibodies and Immunoglobulin G and M Antibodies

机译:特异性检测单纯疱疹病毒1型和2型抗体以及免疫球蛋白G和M抗体的新方法

获取原文

摘要

Recently a few new herpes simplex virus (HSV) type-specific serological diagnostic tests have been introduced to the commercial market, but these tests have some limitations. Moreover, it is not yet clear which commercial test can be regarded as a “gold standard” for the serodiagnosis of HSV infections. In order to improve the clinical diagnostic value of serological tests for the detection of HSV infections, we developed novel, competition-based enzyme-linked immunosorbent assays for the specific determination of HSV type 2 antibodies (SeroHSV2) and HSV type 1 antibodies (SeroHSV1) and two complementary tests for the detection of HSV immunoglobulin M (IgM) and IgG antibodies (SeroHSV IgM and SeroHSV IgG). These four new kits were evaluated in comparison with some commercial kits for the detection of HSV antibodies that are commonly used at present in Israeli clinical laboratories. The results indicate that SeroHSV2 is highly sensitive (>92%) and highly specific (>94%). SeroHSV2 does not cross-react with other alphaherpesvirus antibodies. SeroHSV1 is highly sensitive (>94%) and specific (>91%) compared to four commercial available kits. SeroHSV IgM is highly specific (>92%) in comparison with other commercial HSV IgM tests. The sensitivity of SeroHSV IgM ranges between 50 and 70% compared to these tests. Further investigation of the discrepant results obtained by using in-house competition tests indicated that SeroHSV IgM is more sensitive. SeroHSV IgG was also found to be highly sensitive (>94%) and highly specific (>92%) compared to the other commercial HSV IgG tests.
机译:最近,一些新的单纯疱疹病毒(HSV)类型特异性血清学诊断测试已引入商业市场,但是这些测试有一些局限性。此外,尚不清楚哪种商业检测可被视为HSV感染血清诊断的“金标准”。为了提高血清学检测对HSV感染检测的临床诊断价值,我们开发了新颖的基于竞争的酶联免疫吸附测定法,用于特异性测定HSV 2型抗体(SeroHSV2)和HSV 1型抗体(SeroHSV1)以及两个补充测试,用于检测HSV免疫球蛋白M(IgM)和IgG抗体(SeroHSV IgM和SeroHSV IgG)。与四种用于检测以色列临床实验室目前常用的HSV抗体的商业试剂盒相比,对这四种新试剂盒进行了评估。结果表明,SeroHSV2具有高度敏感性(> 92%)和高度特异性(> 94%)。 SeroHSV2不会与其他α疱疹病毒抗体发生交叉反应。与四种市售试剂盒相比,SeroHSV1具有高度敏感性(> 94%)和特异性(> 91%)。与其他商业HSV IgM测试相比,SeroHSV IgM具有高度特异性(> 92%)。与这些测试相比,SeroHSV IgM的灵敏度介于50%和70%之间。通过使用内部竞争测试获得的不一致结果的进一步调查表明,SeroHSV IgM更敏感。与其他商业HSV IgG测试相比,还发现SeroHSV IgG具有高度敏感性(> 94%)和高度特异性(> 92%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号